CompareMarketResearchRequest a sample
Home / Healthcare / Next Generation Sequencing

Healthcare · Market report

Next Generation Sequencing Market Size, Share and Forecast 2026-2036

The global next generation sequencing market is worth USD 16.4 bn in 2026 and is forecast to reach USD 55.6 bn by 2036, growing at a 13.0% CAGR. United States is the largest country market and Consumables and reagents is the largest by product segment.

USD 16.4 bnMarket size 2026
USD 55.6 bnForecast 2036
13.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global next generation sequencing market is worth USD 16.4 bn in 2026 and is forecast to reach USD 55.6 bn by 2036, growing at a 13.0% CAGR. United States is the largest country market and Consumables and reagents is the largest by product segment.

ScopeSequencers, reagents and consumables, and sequencing services used to read DNA and RNA at scale for research, clinical testing and agriculture.
IndustryHealthcare
Value 2025USD 14.5 bn
Value 2026USD 16.4 bn
Value 2036USD 55.6 bn
CAGR 2026-203613.0%
Volume 202629.1 million samples
Volume 2036134 million samples
Average price 2026USD 563 per sample
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Next Generation Sequencing market size and forecast, 2026-2036

Exhibit 1The global next generation sequencing market is forecast to grow from USD 16.4 bn in 2026 to USD 55.6 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 13.0%
Next Generation Sequencing market value, 2025 to 2036Market value by year. 2025: USD 14.5 bn; 2026: USD 16.4 bn; 2027: USD 18.5 bn; 2028: USD 20.9 bn; 2029: USD 23.6 bn; 2030: USD 26.7 bn; 2031: USD 30.2 bn; 2032: USD 34.1 bn; 2033: USD 38.5 bn; 2034: USD 43.6 bn; 2035: USD 49.2 bn; 2036: USD 55.6 bn. Compound annual growth rate 2026 to 2036: 13.0%.202516.4 bn202630.2 bn203155.6 bn203613.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 16.4 bn
2027USD 18.5 bn
2028USD 20.9 bn
2029USD 23.6 bn
2030USD 26.7 bn
2031USD 30.2 bn
2032USD 34.1 bn
2033USD 38.5 bn
2034USD 43.6 bn
2035USD 49.2 bn
2036USD 55.6 bn

Next Generation Sequencing market segmentation

By product

Exhibit 2Consumables and reagents is the largest segment by product, with 62.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Next Generation Sequencing market share by product, 2026Share of 2026 revenue by product. Consumables and reagents: 62.0%; Services: 22.0%; Instruments: 16.0%.Consumables and reagents62.0%Services22.0%Instruments16.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Consumables and reagents62.0%63.8%USD 10.2 bn13.3%
Instruments16.0%11.5%USD 2.6 bn9.3%
Services22.0%24.7%USD 3.6 bn14.3%

By application

Exhibit 3Clinical oncology adds the most revenue by application, growing from USD 4.9 bn in 2026 to USD 18.2 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Next Generation Sequencing market by application, 2026 and 2036Revenue by application in 2026 and 2036. Clinical oncology: USD 4.9 bn in 2026, USD 18.2 bn in 2036, change +270%; Research and drug discovery: USD 5.6 bn in 2026, USD 15.8 bn in 2036, change +183%; Reproductive and genetic health: USD 3.3 bn in 2026, USD 11.1 bn in 2036, change +239%; Infectious disease and other: USD 2.6 bn in 2026, USD 10.6 bn in 2036, change +303%.20262036 forecastChangeClinical oncology+270%4.9 bn18.2 bnResearch and drug discovery+183%5.6 bn15.8 bnReproductive and genetic health+239%3.3 bn11.1 bnInfectious disease and other+303%2.6 bn10.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Clinical oncology30.0%32.7%USD 4.9 bn14.0%
Reproductive and genetic health20.0%19.9%USD 3.3 bn13.0%
Research and drug discovery34.0%28.4%USD 5.6 bn11.0%
Infectious disease and other16.0%19.0%USD 2.6 bn15.0%

By sequencing technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Short-read sequencing62.0%54.0%USD 10.2 bn11.4%
Long-read sequencing24.0%32.0%USD 3.9 bn16.3%
Targeted and nanopore14.0%14.0%USD 2.3 bn13.0%

By workflow

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Sample preparation22.0%20.0%USD 3.6 bn11.9%
Sequencing38.0%35.0%USD 6.2 bn12.1%
Data analysis40.0%45.0%USD 6.6 bn14.3%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Academic and research34.0%30.0%USD 5.6 bn11.6%
Clinical laboratories30.0%34.0%USD 4.9 bn14.4%
Pharma and biotech24.0%24.0%USD 3.9 bn13.0%
Hospitals12.0%12.0%USD 2.0 bn13.0%

Top 25 countries for next generation sequencing by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 86.5% of 2026 revenue and the 25 countries below together hold 96.2%.

Exhibit 4United States is the largest country market at USD 6.9 bn in 2026, and the three largest countries hold 62.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Next Generation Sequencing market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 6.9 bn, 42.0%; China: USD 2.3 bn, 14.0%; United Kingdom: USD 983 mn, 6.0%; Germany: USD 819 mn, 5.0%; Japan: USD 819 mn, 5.0%; France: USD 573 mn, 3.5%; Canada: USD 492 mn, 3.0%; South Korea: USD 492 mn, 3.0%; Australia: USD 410 mn, 2.5%; India: USD 410 mn, 2.5%.United States6.9 bn 42.0%China2.3 bn 14.0%United Kingdom983 mn 6.0%Germany819 mn 5.0%Japan819 mn 5.0%France573 mn 3.5%Canada492 mn 3.0%South Korea492 mn 3.0%Australia410 mn 2.5%India410 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 6.9 bn42.0%USD 21.8 bn12.2%
2ChinaUSD 2.3 bn14.0%USD 9.5 bn15.2%
3United KingdomUSD 983 mn6.0%USD 3.1 bn12.2%
4GermanyUSD 819 mn5.0%USD 2.6 bn12.3%
5JapanUSD 819 mn5.0%USD 2.4 bn11.3%
6FranceUSD 573 mn3.5%USD 1.8 bn12.3%
7CanadaUSD 492 mn3.0%USD 1.6 bn12.2%
8South KoreaUSD 492 mn3.0%USD 1.8 bn14.1%
9AustraliaUSD 410 mn2.5%USD 1.4 bn13.0%
10IndiaUSD 410 mn2.5%USD 2.0 bn17.2%
11SpainUSD 297 mn1.8%USD 1.0 bn13.2%
12ItalyUSD 242 mn1.5%USD 840 mn13.2%
13NetherlandsUSD 200 mn1.2%USD 690 mn13.2%
14BrazilUSD 164 mn1.0%USD 567 mn13.2%
15SwitzerlandUSD 134 mn0.8%USD 467 mn13.3%
16SingaporeUSD 110 mn0.7%USD 378 mn13.2%
17TaiwanUSD 97 mn0.6%USD 339 mn13.4%
18SwedenUSD 82 mn0.5%USD 289 mn13.4%
19DenmarkUSD 62 mn0.4%USD 217 mn13.3%
20IsraelUSD 54 mn0.3%USD 184 mn13.0%
21BelgiumUSD 46 mn0.3%USD 156 mn13.0%
22MexicoUSD 38 mn0.2%USD 128 mn13.0%
23Saudi ArabiaUSD 28 mn0.2%USD 95 mn13.0%
24PolandUSD 23 mn0.1%USD 78 mn13.0%
25TurkeyUSD 18 mn0.1%USD 61 mn13.0%
Rest of worldUSD 618 mn3.8%USD 2.1 bn13.0%
Exhibit 5United States and China account for 56% of the USD 39.2 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Next Generation Sequencing market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 16.4 bn. United States: +USD 14.9 bn; China: +USD 7.2 bn; United Kingdom: +USD 2.1 bn; Germany: +USD 1.8 bn; India: +USD 1.6 bn; 20 other countries: +USD 10.1 bn; Rest of world: +USD 1.5 bn. Market value 2036: USD 55.6 bn.Market value 202616.4 bnUnited States+14.9 bnChina+7.2 bnUnited Kingdom+2.1 bnGermany+1.8 bnIndia+1.6 bn20 other countries+10.1 bnRest of world+1.5 bnMarket value 203655.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Illumina
  • Thermo Fisher Scientific
  • MGI Tech
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Agilent Technologies

Group 2: Regional and specialist players

  • Roche
  • Element Biosciences
  • Ultima Genomics
  • QIAGEN
  • Novogene
  • BGI Genomics
  • Azenta Life Sciences
  • Eurofins Genomics
  • Twist Bioscience

Group 3: Emerging and niche players

  • Singular Genomics
  • Macrogen
  • Psomagen
  • GeneMind Biosciences
  • Berry Genomics
  • CD Genomics

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the next generation sequencing market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 13.0% is calculated from the resulting values.

The market is divided by product, by application, by sequencing technology, by workflow, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the next generation sequencing market?

The global next generation sequencing market is estimated at USD 14.5 bn in 2025 and USD 16.4 bn in 2026.

How fast will the next generation sequencing market grow?

It is forecast to reach USD 55.6 bn by 2036, a compound annual growth rate of 13.0% from 2026, an increase of USD 39.2 bn.

Which country is the largest market for next generation sequencing?

United States is the largest market by revenue at USD 6.9 bn in 2026, 42.0% of the global total. The three largest countries together hold 62.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 17.2% a year from 2026 to 2036.

Which next generation sequencing segment is largest?

In the by product split, Consumables and reagents is the largest segment with 62.0% of 2026 revenue.

Who are the leading next generation sequencing companies?

Global leaders include Illumina, Thermo Fisher Scientific, MGI Tech, Pacific Biosciences.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← New Approach Methodologies Nonclinical Testing Nuclear Medicine →

All Healthcare markets →

Request a sample